je.st
news
Teva Advances Most in Three Weeks on FDA Panel: Tel Aviv Mover
2013-06-10 05:07:15| Biotech - Topix.net
Teva Pharmaceutical Industries Ltd., the world's largest maker of generic drugs, advanced the most in three weeks on prospects the drugmaker will begin selling its generic diabetes pill in the U.S. Shares of the Petach Tikva, Israel-based company gained 2.2 percent, the most since May 16, to 142.2 shekels, or $39.41, at the close in Tel Aviv, ... (more)
Tags: tel
weeks
panel
advances
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||